“Every rule I work on comes back to one person: the patient at a dispensary counter, trusting that the medicine in their hand is safe, accurately tested, and honestly labeled.”
Stephanie Davis is a patient advocate, regulatory compliance professional, and paralegal whose work is focused on a deceptively simple question: can patients trust the cannabis system they depend on? For more than 11 years, she has worked at the intersection of patient access, regulatory compliance, product safety, and public policy, with a consistent focus on ensuring legal access is backed by accurate testing, honest labeling, fair enforcement, and meaningful accountability.
Her patient advocacy began in Colorado, where she helped secure the addition of post-traumatic stress disorder as a qualifying condition for medical marijuana. That change expanded legal access for patients living with PTSD, including many veterans, and helped shape the way she approaches policy work today: as another form of patient care.
In Oklahoma, Davis served as a Legal Assistant at the Oklahoma Medical Marijuana Authority from 2023 to 2024, managing more than 300 regulatory violation cases and earning the agency’s 2023 MVP Award for Integrity. That experience gave her a close view of the gaps that can emerge when a rapidly growing medical cannabis program outpaces the systems needed to protect patients.
Today, her work focuses on those gaps. Davis serves on the working group for Oklahoma House Interim Study 26 085, Examining Medical Marijuana Testing, Transparency, and Public Health Outcomes, authored by Rep. Jacob Rosecrants. To support the study with real-world evidence, she developed an anonymous survey for every license type covering testing accuracy, labeling, and recalls, giving businesses closest to the product a way to identify problems without fear of retaliation. She has also compared Oklahoma’s medical marijuana statute with OMMA rules and identified hundreds of divergences that can help lawmakers see where implementation has drifted from legislative intent.
Davis has also delivered public comment sand Senate briefing materials on OMMA rulemaking and works as a paralegal, helping licensees correct compliance problems before they reach patients. Her work is grounded in the belief that patient safety is not one rule or one agency action. It depends on whether the entire system, from laboratory testing and labeling to recalls and enforcement, is functioning well enough for patients to trust what they are purchasing.
Stephanie Davis is a strong ambassador for the Patient Voice Award because she turns patient concerns into the detailed regulatory, legislative, and compliance work needed to make cannabis systems safer and more accountable.
Cast your vote for Stephanie Davis for the 2026 Patient Voice Award!
Learn more about Stephanie Davis:
LinkedIn profile: https://www.linkedin.com/in/stephanie-davis-27349b324/
If you appreciate ASA's work, sign up for alerts and updates, and make a donation to support ASA's vital mission.
Share this page
